Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Apply
Tocilizumab & Atezolizumab
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step